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Noncaloric sweeteners (NCS) are food additives used to provide sweetness without adding calories.Their consumption has become
more widespread around the world in all age groups, including children. The aim of this study is to show the state of the art
about the intake of noncaloric sweeteners in children, as well as their benefits and consumption risk. Scientific searchers were used
(PUBMED, Scopus, and Scielo) to analyze articles that included keywords (noncaloric sweeteners/saccharin/cyclamate/acesulfame
potassium/aspartame/sucralose/stevia/children) in English, Spanish, and Portuguese. Authors conclude that it is imperative
that health professionals judiciously and individually evaluate the overall benefits and risks of NCS use in consumers before
recommending their use. Different subgroups of the population incorporate products containing NCS in their diet with different
objectives, which should be considered when recommending a diet plan for the consumer. In childhood, in earlier age groups, this
type of additives should be used as a dietary alternative when other forms of prevention in obesity are not sufficient.
1. Introduction
Noncaloric sweeteners (NCS) are food additives whose pur-
pose is to provide sweetness without providing calories or
glycemic effects; these are used in beverages, foodstuffs, med-
icines, and even in mouthwashes [1]. The introduction of
NCS dates back more than a century [2]. NCS are several
magnitudes sweeter than sucrose.
To be able to use NCS they must be approved by inter-
national agencies such as Codex Alimentarius (Food Code),
FDA, and EFSA [3–5]. Despite these rigorous reviews regard-
ing the safety of NCS, there is still a high level of debate about
the use of NCS in food supply, which requires risk assess-
ments to identify potential health problems associated with
the consumption of foods containing NCS. A key aspect of
the risk assessment of chemical foods is the estimation of
dietary exposure. Exposure evaluations require two basic data
sources: (1) food consumption and (2) information on the
concentration of the chemical product in food. Recent intake
assessments have shown that intake of artificial sweeteners
usually does not exceed the associated acceptable daily intake
(ADI) among many population cohorts [6, 7]. At this time,
some studies have presented a probabilisticmodel to estimate
the effect to exposure of food additives, in regard to NCS
such as sucralose and acesulfame in children who have taken
specialized products in medical nutrition [8].
Saccharin, cyclamate, acesulfame potassium, aspartame,
sucralose, and stevia [9] are the sweeteners approved for the
consumption. Soft drinks and other sugar-sweetened bev-
erages represent the largest source of added sugars and the
discretionary calorie diet for children and adults in theUnited
States and other American countries, considering that 4 of 5
leading drinkers worldwide are found In the region (Chile,
Argentina, Mexico, and the United States) [9, 10].
NCS consumption has expanded in South America, as
shown by several studies performed in adults [11–13] and
children [14–16], especially due to the increasing prevalence
of obesity in our region [17].
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However, although NCS are safe [18], consumption in
children raises controversy both in health professionals and
in general public, which hasmeant that the recommendations
for this age group are not similar [19], and in some countries
it is even forbidden to recommend its use [20] (references
to dietary guidelines or indications of pediatrics in at least
5 American countries). The FDA has set an acceptable daily
intake limit (expressed in mg/kg body weight) for each NCS,
and this value is usually set at 1/100 of the level with no
observed adverse effect (tolerable upper intake levels where
there are no observed adverse effects in animal studies) [21].
This opinion provides the use, toxicity, and current guidelines
appropriate for the use of NCS in clinical practice.
Most NCS are not metabolized in the body and thus
are generally considered safe for consumption. Nevertheless,
concern about the toxicity of “nonmetabolized” compounds
prevails in preclinical models [21]. This review aims to show
the state of the art about the consumption of NCS in children,
as well as their benefits and consumption risks.
2. Methodology
Scientific searchers were used (PUBMED, Scopus, Scielo,




Evidence indicates that the consumption of NCS (diet
products and snacks) between meals may offer an optimum
benefit in this subgroup of the population and may reduce
total caloric intake, while consumption withmeals may result
in compensation for the increase in food-related calorie
intake [22]. The Academy of Nutrition and Dietetics states
that NCS should not be used in children <2 years old and
should beminimal or completely restricted during pregnancy
and lactation, as the FDA has stated that use is unsafe [23].
Cyclamate and saccharin should be avoided, while another
NCS can be used in moderate amounts or, even better, not
used at all [24]. On the other hand, some studies [25–27]
have associated the intake of sucralose and aspartame with
migraine in adults. However, this type of studies is limiting
to obtaining general conclusions, since only 3 clinical cases
with positive association have been reported. Although it
is important to analyze and report these investigations to
generate possible safety signals, it would not be appropriate
to issue a conclusive perspective based only on this data.
In a recent research which involved a sample of 100 chil-
dren ages 3 to 15 years old, it was shown that only a small
group (13 participants) had significant improvement in
chronic head pain after exclusion of aspartame intake. The
remaining participants associated headacheswith other foods
and/or additive [28]. Clear limitations of this research such as
nonrandomized design and observational prospective cohort
without control group prevent finding relevant information
on this respect.However, this type of study opens the possibil-
ity of performing experimental designs with this hypothesis.
Children are especially important because they have a
higher intake of food and drink per kilogram of their body
weight [21]. A pediatric epidemiological study has found
a positive correlation between the consumption of NCS
contained in beverages and weight gain; however, conclusive
data are still lacking [22]. In other context, recent studies with
maximal electroshock seizure model (MES) demonstrated
potential anticonvulsant effects of NCS such as acesulfame
potassium, cyclamate, and saccharine; nevertheless this study
was performed in animal, and it would be necessary to
extrapolate it to humans [28].
3. Sweeteners and Dietary Intake
Drinks have been identified as an important source of NCS
in the diet [29]; therefore NCS consumption estimates are
usually based on artificially sweetened drinks or soft drinks.
Consumption of artificially sweetened soda seems to be
increasing in children, both with age and with time [30, 31].
Schoolchildren, especially the younger ones and of lesser
weight, are a group that is usually studied because of the high
probability of overcoming the daily intake (ADI) of each of
the NCS. Evaluations carried out in the United Kingdom
in the 1990s and 2003 indicated that ADI was exceeded by
preschoolers aged between 1.5 and 4.5 years for two NCS
(saccharin and cyclamate) [32].
However, it is currently unlikely that intake will exceed
the ADI because of the large amount of NCS on the market,
resulting in a reduction in the intake of certain NCS unless
only one NCS is preferred. A study in Irish children deter-
mined the intake of 4 NCS. The results showed that the
average daily intake for all four sweeteners (acesulfame K,
aspartame, saccharin, and sucralose) was according to ADI
(17–31%) [6].
A study in Chile [33] has shown that more than 90%
of schoolchildren consume NCS but do not show that the
intake exceeds the ADI; the high consumption of NCS is
reflected mainly in the intake of products such as soft drinks,
packaged juices, and powder juice; however, another study
carried out in Argentine schoolchildren shows that 17%
consume NCS and 1.5% of the population of children and
adolescents surveyed (𝑛 = 190) exceed the ADI for cyclamate
only through the consumption of soft drinks [15]. EFSA
also concluded that ingestion of these NCS would not be
considered a safety concern among this population group,
which is consistent with results reported in other studies [34].
4. Sweeteners and Adipogenesis
Adipogenesis is the cellular process where precursor cells,
mesenchymal stem cells, become an adipocyte cell. This pro-
cess implicates that the precursors or preadipocyte undergo
dramatic changes in phenotype and gene expression. Reg-
ulation of adipocyte differentiation relies largely on its
surrounded environment with activation of specific genes
like phosphorylated peroxisome proliferator-activated recep-
tor 𝛾 (PPAR𝛾) and CCAAT/enhancer-binding protein 𝛼
(C/EBP𝛼), primary drivers of the adipogenic program that
stimulate expression of terminal adipocyte genes such as fatty
acid-binding protein 4 (FABP4) and GLUT4 [35].
Interestingly, many artificial sweeteners are pharmaco-
logically active and can play a role in the regulation of the
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adipogenesis. Simon et al. [36] found that sweeteners such
acesulfame K and saccharin stimulated the adipogenesis and
inhibited the lipolysis in 3T3-L1 cells culture and these effects
were independent of the classical sweet taste receptors, T1R2
and T1R3.
On the other hand, Pandurangan’s group [37] showed
that aspartame reduced 3T3-L1 adipocyte differentiation by
downregulating p-PPAR𝛾, FABP4, andC/EBP𝛼. In this study,
3T3-L1 cells were differentiated during 6 d in the absence
and presence of aspartame and it was observed that aspar-
tame could reduce significantly the lipid accumulation as
evidenced by Oil Red O staining.
In other study, experiments with mice fed with D-xylose
and with high fat diet resulted in the downregulation of
adipogenesis-related genes in visceral adipose tissues. The
authors concluded that D-xylose may play a role in the
attenuation of the adipogenesis in vivo [38].
Regarding stevia, its effect in the adipogenesis process
has not yet been studied; however, a study [35] reported that
stevioside from Stevia rebaudiana has a significant action on
3T3-L1 insulin sensitivity, which meant an enhancement of
glucose uptake, but at the same time an upregulation of genes
related to cellular pathway elicited by insulin.
5. Sweeteners and Obesity
The consumption of sugary beverages shows a positive effect
on adiposity [39]. However, associations are still being con-
troversial [40]. Strong evidence supports the association of
added sugars with the increased risk of cardiovascular disease
in children through increased energy intake, increased adi-
posity, and dyslipidemia [41]. Substitution of caloric sweeten-
ers (usually sugar) with low-calorie alternatives is a strategy
that can help reduce energy consumption, facilitating weight
loss and/or maintenance, and even prevention of weight gain
[42–45].
In a study by de Ruyter et al. 641 schoolchildren with nor-
mal weight were randomly given 250ml of sweetened drink
or diet drink for a period of 18 months. The most important
results were that the z-IMC increased by an average of 0.02
units and the body weight by 6.35 kg in the NCS group, while
the sugar group increased z-IMC by 0.15 units and the body
weight at 7.37 kg.The sum of the skinfolds, waist-height ratio,
and fat mass also increased significantly in both groups but
was lower in the NCS group [46]. On the other hand, in a
randomized controlled trial, girls between 11 and 15 years old
consumed a diet of 1500 kcal/day during 12 weeks. In one
group, sugary drinks were allowed as a snack, while in the
other group only diet soft drinks were allowed. There were
no differences between groups for BMI change [47].
A recent meta-analysis conducted in randomized con-
trolled trials and prospective cohort studies in both children
and adolescents showed that NCS consumption exhibited a
modest but significantly reduced body weight (−0.80 kg; IC
of 95% −1.17, 0.43), BMI (kg/m2): −0.24; IC of 95% −0.41,
−0.07), fat mass (−1.10 kg, IC of 95% CI −1.77, −0.44), and
waist circumference (−0.83 cm, IC of 95% −1, 29, −0.37).
Among prospective cohort studies, NCS intake was not
associated with body weight or fat mass but was significantly
associated with a slightly higher BMI (0.03; IC of 95%: 0.01,
0.06) [48]. In a study by Katan et al. [49], it was found that the
substitution of 250ml per day of sugary drinks for diet drinks
allowed a weight reduction per 1 kg in 18 months.
Various clinical studies have shown that sugar-free bever-
ages reduce weight gain compared to sugar-sweetened bever-
ages and besides NCS consumption allows better adherence
to diet [39, 46–48], which could be an aid in the treatment for
childhood and adolescent obesity [50–52]. A cross-sectional
study that included 571 Chilean schoolchildren between 10
and 16 years old, of both sexes, found no association between
NCS use and obesity risk [14].
On the other hand, three transversal studies, including
385 and 3311 children, showed positive association between
the intakes of NCS and BMI [53]. Similar results were
obtained with pregnant woman who ingested NCS, showing
more probability of having babies with increased risk for later
obesity or overweight. However, the limitation of the studies
is that these were of observational type, and the findings do
not necessarily imply a significant correlation between the
intake of artificial sweeteners and weight gain [54, 55]. In a
meta-analysis of intake of NCS that included 11.774 citations,
7 trials, 1003 participants, and 30 cohort studies (adults and
adolescents) it was concluded that there is not enough evi-
dence from randomized controlled trials to demonstrate the
positive effect ofNCS on controlling bodyweight. Findings of
observational studies suggest that the continuous ingestion of
NCS could be associated with BMI and cardiometabolic risk
increase [56].
6. Other Possible Effects
A study that included 1988 girls showed that the consumption
of soft drinks sweetened with NCS was positively associated
with the risk of earlymenarche (RR of 1 serving/day: 1.43, 95%
IC 1.08, 1, 88) and in particular aspartame (RR for the increase
of 1-SD: 1.20, 95% IC: 1.10, 1.31) was positively associated
with the risk of early menarche; the authors postulate that
the mediator would be insulin [57]; however, caution should
be exercised in interpreting the results for possible reverse
causality. In contrast with these findings, a substantial body of
scientific evidence supports that NCS do not have any effect
on menarche or delayed puberty in girls [58, 59].
Until now, it is not totally clear if there are correlational
associations between NCS intake and raised risk illness in
children; however different studies demonstrate that NSC
could be a better option than sugar-sweetened beverage; it
does not necessarily imply that NCS is totally harmless to
human health. In this context, it is believed that it is possible
that the chronic intake of NCS in children could produce
a negative effect on health; for example, the exposure to
artificial sweeteners during infancy can affect the adult eating
habits and could cause an increase in the consumption of sug-
ars throughout adulthood [60]. In addition to this premise,
the underlying psychological factors are relevant in the food
industry, as they influence the selection of food by the child
population. Minimum standards on nutritional content of
these products are required to ensure that they comply with
the nutritional recommendations of this age group [61].
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Table 1: Number of Publications that show risks versus benefits of the use of artificial sweeteners and number of studies in humans and
animal models.
Year of publicationNumber of study benefits Number of study risks Total Number of animals models Number of human studies Total
16 21 11 26
2000–2005 2 4 6 0 6 6
2006–2012 6 2 8 5 3 8
2013–2017 8 15 23 6 17 23
Total 16 21 37 11 26 37
Other aspect of NCS is about the rewarding postintake
feedback, because NCS produce sweet taste without giving
calories. Studies of Frank et al., [39] and Smeets et al.,
[62] demonstrated that sucrose, but not NCS, could elicit
the reward pathway. Moreover, NCS is not able to produce
postprandial release of insulin, GLP-1, or GIP [63], which
can finally produce a subsequent feeling of dissatisfaction
with additional food intake compensation. Interestingly,
Wang et al., studying sucralose demonstrated that chronic
consumption of a sweet/energy imbalanced diet promoted
an increase in food intake in mammals through a NPY-
dependent mechanism, triggering a conserved neuronal
response in fasting and increasing motivation to eat [64].
Likewise, certain studies have related a negative impact of
NCS on gut microbiota [65, 66] which, in turn, could be a
factor towards the development of obesity and insulin resis-
tance. Particularly, the artificial sweetener saccharin could
alter gut microbiota and induce glucose intolerance, raising
questions about the contribution of artificial sweeteners to
the global epidemic of obesity and diabetes. In this regard,
a study found that consumption of a nonnutritive sweetener
containing 1% sucralose impaired the growth of gut bacteria
in rats [67]. In addition, a recent study found that noncaloric
artificial sweeteners, such as saccharin, impaired glucose
tolerance by modulating the composition of gut bacteria
[68]. A recent research found that Ace-K consumption per-
turbed gut microbiome of CD-1 mice after a 4-week treat-
ment [69]. The observed body weight gain shifts in the
gut bacterial community composition, the enrichment of
functional bacterial genes related to energy metabolism, and
the fecal metabolomics changes were highly gender-specific
with differential effects observed for males and females.
However, the number of specific studies on themicrobiome is
very limited, and currently research in this area with specific
effects in childhood has not yet been developed.
In another context, one of the possible benefits of sweet-
ener consumption in children is its anticariogenic effect.
The sugars in sticky foods consumed between meals were
associated with high cariogenic activity. These findings stim-
ulated the investigation of nonacidogenic sugar substitutes
(sweeteners) that do not cause pHdrops in dental plaque [70].
Fermentable carbohydrates of the diet give place to acidic
material that destroys the hard dental tissue, causing cavities.
In the infant population, in addition to fluoride deficiency,
cavities are still frequent because after the intake of sweet
foods there is usually no adequate oral hygiene [71]. On
the other hand, in infants, the use of juices or other sugary
beverages rich in fructose or sucrose, for long time, increases
the risk of dental damage. Among the sweeteners that have
been declared with healthy properties to avoid this pathology,
there are the polyalcohols of sugar or the sucralose among
others [72]. The risks and benefits of NCS are shown in
Table 1.
Finally, it is important to note that NCS are used clini-
cally in products for pediatric use, for example, in protein
substitution formulas in which sucralose is added for patients
with phenylketonuria and other inborn errors of metabolism
[8]. Similarly, this NCS has been used to sweeten specific
enteral formulas for patients with diabetes, with favorable
glycemic and insulin responses in healthy and diabetic adults.
However, it is necessary to conduct scientific research in
this specific field to evaluate the metabolic effect of NCS on
health, especially in children and adolescents with diabetes
[73–75].
7. Conclusions
It is imperative that health professionals judiciously and
individually evaluate the overall benefits and risks of NCS
use in consumers before recommending their use. Different
subgroups of the population incorporate products containing
NCS in their diet with different objectives; however, these
types of additives should be used in children belonging to
earlier age groups, only as a dietary alternative when other
forms of prevention in obesity are not sufficient. Since the
use of artificial sweeteners has increased in the last decades,
it is clear that it is crucial to perform more studies in order
to determine more accurately the effect of NCS on health, in
order to elaborate recommendations with scientific support
for the prevention and treatment of children obesity.
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